Come back to this blog post periodically to read about the clinical trials currently recruiting people just like you!

DIAGNODE-3

Purpose: to explore whether an investigational drug, Diamyd (rhGAD65), is able to preserve the body’s own insulin-producing ability

What’s required: three injections, followed by a 22-month follow-up period; must be able to travel to Barbara Davis Center

Who can participate: individuals ages 12 through 29 diagnosed with T1D in the past 6 months who have a certain genetic risk for T1D (HLA haplotype DR3-DQ2)

Learn more about this study here!

FINE-ONE

Purpose: to learn if finerenone is safe and effective in preventing the progression of chronic kidney disease in people with T1D

What’s required: participation for potentially up to 7.5 months, taking study treatments for 6 months, with visits to the study site at least 6 times

Who can participate: adults over the age of 18 who have lived with T1D for at least one year

Learn more about this study and your eligibility here!

JAKPOT T1D

Purpose: to see if two different treatments – abrocitinib and ritlecitinib (a new class of autoimmune treatments called Janus kinase [JAK] inhibitors) – can preserve insulin production in people newly diagnosed with T1D

What’s required: a treatment over 1 year (where you will visit a study site every 3 months for tests), plus a 1-year follow-up phase (where you will visit a study site every 6 months)

Who can participate: individuals ages 12 through 35 who have been diagnosed with T1D in the past 3 months

Learn more about this study and share your interest in participating here!

Patients’ and Carers’ Perceptions on Routine Mental Health Screening in Pediatric Diabetes Care

Purpose: to understand how people with diabetes and their caregivers perceive their healthcare team’s role in screening for psychological concerns

What’s required: a 15-minute survey

Who can participate: individuals ages 12 through 18 who live with diabetes, or caregivers of someone who matches that criteria

Take the survey here!

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT) Trial

Purpose: to examine the potential of an SGLT inhibitor, sotagliflozin, to prevent or delay the progression to kidney failure in T1D

What’s required: ability to participate in a 3-year trial

Who can participate: individuals ages 19 through 75 who have been living with T1D for at least 8 years and have chronic kidney disease

Learn more about this study here!

The Teen Interview on Diabetes Eating Survey (TIDES)

Purpose: to better understand how teenagers with T1D answer standard survey questions about diabetes and eating in order to see if updates need to be made

What’s required: the teen would complete brief questionnaires, followed by a virtual interview with a study staff member

Who can participate: teens with T1D ages 13 through 17

Incentive: compensation for time

Find out if you’re eligible here!

Type 1 Diabetes Adolescents for healthier Lifestyle (T1DAL) Study

Purpose: to test out a new healthy lifestyles program designed specifically for teenagers with T1D

What’s required: the teen would attend one 75-minute virtual session per week for 16 weeks, with each group containing 4-8 other teens

Who can participate: teens ages 13 through 18 who have been diagnosed with T1D for at least 6 months

Incentive: teens can earn up to $125 and parents/caregivers can earn up to $80

Fill out this survey to share your interest!

For a treatment, drug, or device to make it into the hands of people with T1D, it first needs your help to complete a vital step – a clinical trial. Learn more about how you can impact T1D breakthroughs through research and clinical trials here.